Full text is available at the source.
The therapeutic potential of dietary intervention: based on the mechanism of a tryptophan derivative-indole propionic acid on metabolic disorders
Dietary treatment potential based on how indole propionic acid, a tryptophan byproduct, affects metabolic disorders
AI simplified
Abstract
Tryptophan metabolites, particularly indole propionic acid (IPA), may affect host health and disease.
- IPA can activate the immune system through specific receptors, influencing host and microbe interactions.
- Different levels of IPA in the bloodstream may predict the risk of non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), and cardiovascular disease (CVD).
- IPA is associated with the reduction of cognitive impairment caused by oxidative damage and gut inflammation.
- It may help inhibit fat accumulation in the liver and improve symptoms of NAFLD.
- IPA is suggested to enhance the intestinal barrier and support overall gut health.
AI simplified